The trademark application ZANOVERSE was filed by MEI Pharma Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 5, 2021, and it was registered by office on November 12, 2021 without any oppositions.
The application was filed in Danish (English was selected as the second language).
Appointment and Replacement of representative of the trademark registration was recorded on September 2, 2024.